Stalmans Ingeborg

Martinez-de-la-Casa Jose, Stalmans Ingeborg, Abegão-Pinto Luís, Topouzis Fotis, Pazos Marta, Beckers Heny et al.

Cordeiro M Francesca, Oddone Francesco, Mermeklieva Elena Atanasova, Rokicki Dariusz Md, Nisslé Sylvie, Gościniewicz Piotr et al.

This study found a new low-concentration bimatoprost/timolol gel is as effective as standard drops for glaucoma/OHT, offering a safe, comparable treatment option.

Vilares-Morgado Rodrigo, Verbruggen Kamiel, Stalmans Ingeborg, Barbosa-Breda João

This review found healthy aging causes a progressive decrease in OCT glaucoma parameters (e.g., RNFL, GCIPL). Clinically, this "normal" age-related thinning must be factored when assessing glaucoma progression to avoid misdiagnosis.

Armstrong James J, De Francesco Ticiana, Beckers Henny J, Stalmans Ingeborg, Fea Antonio M, Sng Chelvin C A et al.

This study compared three primary glaucoma surgeries, finding SIBS microshunt achieved higher success and fewer complications than gelatin microstent or trabeculectomy, suggesting it's a superior option.

Duarte Susana R, Lima-Cabrita Afonso, Barão Rafael C, Barata André, Brito Cristina, Stalmans Ingeborg et al.

Preserflo MicroShunt effectively lowered IOP and reduced medications in pediatric glaucoma patients over two years, showing a favorable safety profile, making it a viable surgical option.

Fhima Jonathan, Van Eijgen Jan, Reiner-Benaim Anat, Beeckmans Lennert, Abramovich Or, Stalmans Ingeborg et al.

Automated analysis of retinal images found that primary open-angle glaucoma causes retinal vascular changes similar to accelerated aging, offering a tool for understanding ocular and systemic vascular health.

Baudouin Christophe, Stalmans Ingeborg, Bourne Rupert, Larrosa Jose Manuel, Schmickler Stefanie, Seleznev Aleksey et al.

Preservative-free latanoprost effectively lowered IOP similar to preserved latanoprost in glaucoma/OHT, while also improving ocular surface disease signs, offering a better option for patient comfort.

Berteloot Sophie, Correia Barão Rafael, Abegão Pinto Luís, Vandewalle Evelien, Stalmans Ingeborg, Lemmens Sophie

This study compared Paul and Baerveldt glaucoma implants, finding both safe and effective at one year for uncontrolled glaucoma, with similar success rates and IOP reduction.

Muñoz-Negrete Francisco J, Topouzis Fotis, Oddone Francesco, Nisslé Sylvie, Rokicki Dariusz, Januleviciene Ingrida et al.

This study found preservative-free bimatoprost 0.01% gel is as effective as preserved bimatoprost for glaucoma/ocular hypertension, with improved tolerability, particularly less conjunctival hyperemia, offering a better patient experience.

Abegao Pinto Luis, Sunaric Mégevand Gordana, Stalmans Ingeborg, Azuara-Blanco Augusto, Bron Alain, Garcia Feijoo Julian et al.

This EGS guide explores new glaucoma surgeries, aiming to provide evidence-based answers on their safety, efficacy, and role compared to traditional methods, to help clinicians make informed, individualized treatment decisions.

Correia Barão Rafael, Hemelings Ruben, Abegão Pinto Luís, Pazos Marta, Stalmans Ingeborg

AI is improving glaucoma diagnosis and progression detection using imaging, showing promise for clinical integration despite current challenges in generalizability and explainability.

Sulonen Sakari, Leinonen Sanna, Lehtonen Eemil, Hujanen Pekko, Vaajanen Anu, Syvänen Ulla et al.

A structured EHR for glaucoma enabled real-world data comparison, revealing high diagnostic test completion and differences in visit patterns and test intervals compared to other populations, aiding care evaluation.

Stalmans Ingeborg, Lim Kin Sheng, Oddone Francesco, Fichtl Marek, Belda Jose I, Hommer Anton et al.

This study found netarsudil/latanoprost was non-inferior to bimatoprost/timolol in lowering IOP for glaucoma/ocular hypertension. It offers an effective alternative fixed-dose combination, though with different side effect profiles.

Rossetti Luca, Goni Francisco, Montesano Giovanni, Stalmans Ingeborg, Topouzis Fotis, Romano Dario et al.

This study found citicoline oral solution improved vision-related quality of life in glaucoma patients, particularly those more affected. This suggests a potential adjunctive therapy for glaucoma-related visual impairment.

Lauwers Amelien, Barbosa Breda João, Stalmans Ingeborg

This review found untreated glaucoma progression rates vary, with pseudoexfoliation glaucoma progressing fastest. This informs prognosis, but individual monitoring remains crucial.

Hemelings Ruben, Elen Bart, Barbosa-Breda João, Bellon Erwin, Blaschko Matthew B, De Boever Patrick et al.

Deep learning accurately estimated glaucoma visual field sensitivities (global and pointwise) from OCT scans, offering a consistent alternative for patients unable to perform reliable visual field tests.

José Patrícia, Teixeira Filipa Jorge, Barão Rafael, Sousa David Cordeiro, Marques Raquel Esteves, Barata Andre Diogo De Oliveira et al.

This study found adding intracamerular bevacizumab to trabeculectomy with MMC significantly improved absolute success rates and achieved lower IOPs, particularly useful for patients needing very low target pressures.

Miguel Ana, Silva André, Barbosa-Breda Joao, Azevedo Luis, Abdulrahman Abdulkarim, Hereth Esther et al.

OCTA detects progressive microvascular loss in glaucoma patients, with rates varying. This non-invasive tool shows promise for monitoring glaucoma, but standardization is crucial for future clinical use.

Andrade De Jesus Danilo, Sánchez Brea Luisa, Barbosa Breda João, Fokkinga Ella, Ederveen Vera, Borren Noor et al.

This study found OCTA microvascular analysis performs similarly to RNFL thickness for glaucoma diagnosis, but better for staging severity, suggesting its value as a complementary tool in glaucoma management.

Albis-Donado Oscar, Rodríguez-Camacho Brenda, Bhartiya Shibal, Ramírez-Neria Paulina, López-Star Ellery, González-Daher Pamela et al.

This pilot study found acute atmospheric pressure changes affect GAT and DCT intraocular pressure readings differently, with their measurement difference increasing at lower atmospheric pressures.

Marques Raquel Esteves, Sousa David Cordeiro, Vandewalle Evelien, Somers Alix, Melamed Shlomo, Nardi Marco et al.

Ultrasound cycloplasty for glaucoma increased corneal astigmatism, but its impact on overall refractive astigmatism was less significant, suggesting minimal visual effect.

Bekkers Amerens, Borren Noor, Ederveen Vera, Fokkinga Ella, Andrade De Jesus Danilo, Sánchez Brea Luisa et al.

This review found peripapillary OCTA vascular density, especially in superior/inferior superficial sectors, is most discriminative for glaucoma diagnosis, highlighting its clinical value as a complementary tool.

Tan Nicholas Y Q, Friedman David S, Stalmans Ingeborg, Ahmed Iqbal Ike K, Sng Chelvin C A

AI and telemedicine show promise for more accurate, affordable, and accessible glaucoma screening, especially in underserved populations, but further implementation research is needed.

Reitsamer Herbert, Sng Chelvin, Vera Vanessa, Lenzhofer Markus, Barton Keith, Stalmans Ingeborg

A gelatin implant effectively lowered eye pressure and medication needs for two years in medically uncontrolled primary open-angle glaucoma, offering a safe and viable treatment option.

Bevers Claudia, Blanckaert Gauthier, Van Keer Karel, Fils Jean-François, Vandewalle Evelien, Stalmans Ingeborg

This study found automated kinetic perimetry (HFA3, Octopus 900 without reaction time vector) produces comparable V4e visual fields to Goldmann perimetry, suggesting they are promising clinical replacements.